| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$297 |
Update - Notification of buy-back - SVR
|
9 May 2025 8:28AM |
$1.700 |
$1.570 |
fallen by
7.65%
|
|
| Computershare Limited (CPU) ORDINARY FULLY PAID |
Industrials |
$17,774 |
Update - Notification of buy-back - CPU
|
9 May 2025 8:28AM |
$39.190 |
$30.730 |
fallen by
21.59%
|
|
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,543 |
Update - Notification of buy-back - KAR
|
9 May 2025 8:28AM |
$1.440 |
$2.170 |
risen by
50.69%
|
|
| Atturra Limited (ATA) ORDINARY FULLY PAID |
Information Technology |
$166 |
Update - Notification of buy-back - ATA
|
9 May 2025 8:28AM |
$0.855 |
$0.450 |
fallen by
47.37%
|
|
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$198 |
Update - Notification of buy-back - CAA
|
9 May 2025 8:28AM |
$10.730 |
$12.390 |
risen by
15.47%
|
|
| Macquarie Group Limited (MQG) ORDINARY FULLY PAID |
Financials |
$90,783 |
Macquarie Group FY25 Shareholder Email
|
9 May 2025 8:28AM |
$195.890 |
$238.190 |
risen by
21.59%
|
|
| QBE Insurance Group Limited (QBE) ORDINARY FULLY PAID |
Financials |
$33,571 |
2025 AGM Addresses
|
9 May 2025 8:27AM |
$21.830 |
$22.470 |
risen by
2.93%
|
|
QBE - Price-sensitive ASX Announcement
Full Release
Key Points
- Annual addresses at the 2025 QBE AGM were delivered by the Chair and Group Chief Executive Officer.
- Key topics discussed included QBE’s performance, financial results, and strategic direction.
- Emphasis was placed on capital management, operational improvement, and disciplined underwriting.
- Shareholder questions and related Board responses were addressed.
- Updates on sustainability, ESG, and QBE’s climate-related initiatives were presented.
- Discussion of global market trends and QBE’s positioning within the insurance industry.
- Focus on technology investments and digitalisation efforts to drive efficiency.
- Commitment to risk management and improved claims performance.
- Outlook for 2025 highlights challenges and opportunities in the insurance landscape.
- QBE reaffirmed its ongoing commitment to creating long-term value for shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| QBE Insurance Group Limited (QBE) ORDINARY FULLY PAID |
Financials |
$33,571 |
1Q25 Performance Update
|
9 May 2025 8:27AM |
$21.830 |
$22.470 |
risen by
2.93%
|
|
QBE - Price-sensitive ASX Announcement
Full Release
Key Points
- QBE delivered strong gross written premium growth in 1Q25, supported by premium rate momentum and new business opportunities.
- The company sustained improved underwriting margins and maintained disciplined risk selection.
- Portfolio simplification and focus on core business lines contributed to performance and resilience.
- Catastrophe claims costs were within budgeted allowances for the quarter.
- Investment income benefited from elevated yields in the fixed income portfolio.
- Operating expense ratio remained stable, reflecting ongoing cost discipline.
- QBE reiterated its FY25 outlook and remains focused on ongoing strategic execution.
- The Group is prioritizing continued improvement in claims management and operational efficiency.
- Technology and data investments are supporting better risk assessment and process automation.
- QBE's capital position remains strong and supportive of its growth ambitions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$4,925 |
Quarterly Dividend
|
9 May 2025 8:26AM |
$2.160 |
$1.665 |
fallen by
22.92%
|
|
GQG - Price-sensitive ASX Announcement
Full Release
Key Points
- GQG Partners Inc. declared a quarterly dividend for the quarter ended March 31, 2024.
- Dividend amount is AUD 3.0 cents per share.
- Record date for the dividend is May 15, 2024.
- Dividend payment date is May 30, 2024.
- Declaration reflects strong financial performance and commitment to shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,775 |
FY2025 Third Quarter Earnings Release
|
9 May 2025 8:26AM |
$50.680 |
$42.700 |
fallen by
15.75%
|
|
NWS - Price-sensitive ASX Announcement
Full Release
Key Points
- News Corporation reported FY2025 Third Quarter Earnings for the period ended March 31, 2024.
- Consolidated revenues showed year-over-year growth, driven primarily by strong results in Digital Real Estate Services and Dow Jones.
- Adjusted EBITDA increased compared to the prior-year quarter, reflecting continued operational improvements.
- Digital Real Estate Services segment saw robust revenue and earnings growth, fueled by strong digital listings and higher consumer engagement.
- Dow Jones delivered solid results, with increased digital subscriptions and strong performance in professional information business.
- Book Publishing segment experienced lower revenues due to fewer frontlist title releases and ongoing market challenges.
- Subscription Video Services faced revenue pressures from a changing industry landscape and subscriber declines.
- News Media segment revenues remained stable, with digital advertising and subscription revenues partially offsetting declines in print.
- The company continued to reduce costs and drive efficiencies across all segments.
- News Corporation emphasized strategic initiatives focused on digital transformation, margin improvement, and shareholder returns.
- Management commentary expressed cautious optimism for the remainder of the fiscal year, citing macroeconomic challenges and a focus on profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$4,925 |
FUM as at 30 April 2025
|
9 May 2025 8:26AM |
$2.160 |
$1.665 |
fallen by
22.92%
|
|
GQG - Price-sensitive ASX Announcement
Full Release
Key Points
- GQG Partners Inc. announced FUM as at 30 April 2025.
- FUM reached A$151.6 billion.
- The FUM figure reflects an increase from previous reporting periods.
- Breakdown provided by investment strategy and currency base.
- Growth observed across global and emerging markets equity strategies.
- Commitment to transparency with monthly FUM reporting.
- No other major company updates or operational changes disclosed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coronado Global Resources Inc (CRN) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$469 |
As Filed SEC Form 10-Q Q1 2025
|
9 May 2025 8:26AM |
$0.170 |
$0.280 |
risen by
64.71%
|
|
CRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Coronado Global Resources Inc. filed its Q1 2025 SEC Form 10-Q for the period ended March 31, 2024.
- The report covers financial results, including revenues, costs, profits, and production volumes.
- Market conditions impacting coal prices and demand are discussed, emphasizing metallurgical coal.
- Operational challenges, such as adverse weather and geological events, are noted.
- Liquidity position, capital resources, and expenditure plans are outlined.
- Legal proceedings, contingent liabilities, and risk factors are disclosed.
- The company addresses its sustainability, safety, and environmental initiatives.
- Analysis includes management’s discussion and analysis, as well as financial statements.
- Risk management strategies and controls and procedures are described.
- Potential impacts of market volatility, regulatory changes, and commodity price risks are discussed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Laramide Resources Ltd (LAM) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$16 |
Notification regarding unquoted securities - LAM
|
9 May 2025 8:26AM |
$0.755 |
$0.760 |
risen by
0.66%
|
|
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$105 |
Financial Results for Quarter Ending 31 March 2025
|
9 May 2025 8:25AM |
$2.990 |
$1.210 |
fallen by
59.53%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Product revenue increased significantly year-over-year, mainly due to higher adoption of RECELL in the U.S.
- Clinical development advanced with ongoing trials in soft tissue reconstruction and vitiligo.
- Gross profit improved, reflecting favorable product mix and operational efficiencies.
- Operating expenses rose as a result of investments in sales, marketing, and research activities.
- Net loss was reported, but the company emphasized a strong cash position to support future operations.
- Key milestones were achieved in regulatory submissions and clinical programs.
- Strategic initiatives focused on expanding addressable markets and driving adoption.
- Positive outlook for continued revenue growth through expanded indications and market reach.
- Management reiterated commitment to innovation and improving patient outcomes.
- Financial guidance and strategic priorities for the upcoming quarters were provided.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$105 |
AVITA Medical Q1 2025 Earnings Presentation
|
9 May 2025 8:25AM |
$2.990 |
$1.210 |
fallen by
59.53%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Q1 2025 earnings presentation delivered on May 9, 2024
- Continued expansion of RECELL device in U.S. burn and soft tissue repair markets
- Transitioned to a direct sales model in Canada to drive commercial performance
- Achieved key regulatory milestones, including FDA approvals and product label expansions
- Advanced multiple pipeline projects, such as RECELL GO and new indications
- Strengthened operational efficiency and reduced operating expenses year-over-year
- Reported increased quarterly revenues and improved gross margin
- Maintained strong cash position to support business initiatives
- Reiterated fiscal year 2025 financial guidance and growth expectations
- Strategic focus on market expansion, innovation, and operational excellence
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$105 |
AVITA Medical Reports Q1 2025 Financial Results
|
9 May 2025 8:25AM |
$2.990 |
$1.210 |
fallen by
59.53%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- AVITA Medical, Inc. reported its Q1 2025 financial results, showing continued revenue growth.
- The company’s RECELL product line drove increased adoption in wound care and burn treatment segments.
- Operational highlights included commercial expansion and new product development initiatives.
- AVITA Medical provided updates on regulatory approvals and ongoing clinical trials.
- The company continues to focus on strategic market expansion and strengthening its financial position.
- Management emphasized commitment to innovation and long-term growth opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sims Limited (SGM) ORDINARY FULLY PAID |
Materials |
$4,116 |
Application for quotation of securities - SGM
|
9 May 2025 8:25AM |
$15.270 |
$21.300 |
risen by
39.49%
|
|
| Genmin Limited (GEN) ORDINARY FULLY PAID |
Materials |
$21 |
Non-executive Chair provides A$2.0 million in funding
|
9 May 2025 8:25AM |
$0.027 |
$0.006 |
fallen by
77.78%
|
|
GEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Genmin Limited received A$2.0 million funding from Non-executive Chair Mr. Kerry Stokes AC.
- The funding is structured as an unsecured loan with a 12-month maturity period.
- Interest on the loan is set at 8% per annum, payable quarterly in arrears.
- The funds will be used to support Genmin's working capital and ongoing operations.
- The transaction was on arm's length terms and not considered a related party transaction under ASX rules.
- The funding demonstrates continued board support as Genmin advances its African iron ore projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Winchester Energy Limited (WEL) ORDINARY FULLY PAID |
Energy |
$3 |
Winchester successfully defends legal proceedings
|
9 May 2025 8:25AM |
$0.001 |
$0.002 |
risen by
100%
|
|
WEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Winchester Energy Limited has successfully defended legal proceedings.
- The court ruled in favor of Winchester, dismissing all claims.
- No adverse findings or damages were imposed on the company.
- No costs were awarded to the plaintiff.
- The outcome removes legal uncertainty for Winchester Energy Limited.
- The company assures shareholders of its strong legal position.
- Winchester will now focus on ongoing business operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Piedmont Lithium Limited (PLL) ORDINARY FULLY PAID |
Materials |
- |
Earnings Presentation Q1 2025
|
9 May 2025 8:25AM |
$0.100 |
$0.140 |
risen by
40%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,848 |
Ceasing to be a substantial holder
|
9 May 2025 8:24AM |
$1.745 |
$2.200 |
risen by
26.07%
|
|
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$462 |
Ceasing to be a substantial holder
|
9 May 2025 8:24AM |
$11.270 |
$9.170 |
fallen by
18.63%
|
|
| 8Common Ltd (8CO) ORDINARY FULLY PAID |
Information Technology |
$6 |
Change of Director's Interest Notice - N Lim
|
9 May 2025 8:24AM |
$0.015 |
$0.025 |
risen by
66.67%
|
|
| Doctor Care Anywhere Group PLC (DOC) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$59 |
Change of Director's Interest Notice - John Stier
|
9 May 2025 8:24AM |
$0.084 |
$0.160 |
risen by
90.48%
|
|
| Mineral Resources Limited (MIN) ORDINARY FULLY PAID |
Materials |
$13,182 |
Ceasing to be a substantial holder
|
9 May 2025 8:24AM |
$20.740 |
$66.700 |
risen by
221.60%
|
|
Call 1300 880 160
Start a chat
Schedule a call
